What is more, other mutated genes, such as TTN, MUC16, and RYR2, all previously reported to regulate tumorigenesis and chemoresistance in lung cancer, were the most common mutations in both cohorts [24, 25], indicating a lack of significant immune infiltration. The gene discussed is MUC16; the disease is lung cancer.